Prospective Study : Podocyturia as Predictive Factor for Pre-eclampsia

Hospices Civils de Lyon1 site in 1 country1,000 target enrollmentMay 15, 2019

ConditionsPre-Eclampsia

Overview

Phase: Not Applicable
Intervention: Not specified
Conditions: Pre-Eclampsia
Sponsor: Hospices Civils de Lyon
Enrollment: 1000
Locations: 1
Primary Endpoint: Occurrence of pre-eclampsia
Status: Completed
Last Updated: 4 years ago

Overview Investigators Eligibility Criteria Outcomes Sites Similar Trials

Overview

Brief Summary

Pre-eclampsia is an hypertensive disorder appearing during pregnancy, inducing serious maternal, fetal and neonatal mortality and morbidity. Podocyn could be identified in the urine, before proteinuria, a key element in the diagnostic of pre-eclampsia. Preventive treatment using aspirin could be administrated in early pregnancy. We hypothesized that podocyturia could be an early indicator of preeclampsia. This is a prospective, non-interventional, monocentric study.

Registry

clinicaltrials.gov

Start Date

May 15, 2019

End Date

December 7, 2021

Last Updated

4 years ago

Study Type

Observational

Sex

Female

Investigators

Sponsor

Hospices Civils de Lyon

Responsible Party

Sponsor

Eligibility Criteria

Inclusion Criteria

•women aged 18 years or more
•single pregnancy
•first planned prenatal visit before 16 weeks of gestation
•planned delivery at Hôpital Femme Mère Enfant in Lyon, France
•patient receiving information and non opposition to participate

Exclusion Criteria

•multiple pregnancy
•pregnancy stopped
•antecedent of nephropathy
•inability to understand information provided
•prisoner or under administrative supervision
•fetal malformation, chromosomal anomalies
•preterm delivery for other reason that any hypertensive disorder of pregnancy or Intrauterine growth restriction